NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved BOTOX® for the treatment of ...
Elderly woman Medications for storage and voiding symptoms were often prescribed for detrusor underactivity. Detrusor underactivity in older adults appears to gradually worsen over time with no ...
Myrbetriq (mirabegron extended-release tablets) is now approved for treatment of neurogenic detrusor overactivity, common in patients with spina bifida, in children 3 years and older, the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results